AF
ALPN

Amalgamated Financial’s Alpine Immune Sciences Inc ALPN Stock Holding History

Amalgamated Financial’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$17K Buy
+1,891
New +$16.4K ﹤0.01% 2792

Other funds holding ALPN

DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Amalgamated Financial's ALPN Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Alpine Immune Sciences Inc (ALPN) in Q1 2022: 1,891 shares worth $17K. The stake represents ﹤0.01% of the portfolio and ranks #2792 among its holdings.

56 funds tracked by Wall St. Rank hold ALPN as of Q1 2022.

  • Amalgamated Financial held 1,891 shares of Alpine Immune Sciences Inc worth $17K as of Q1 2022.
  • Alpine Immune Sciences Inc was a new Amalgamated Financial position in Q1 2022.
  • Alpine Immune Sciences Inc made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2792 holding.
  • 56 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.